# Shandong Buchang Pharmaceuticals Co.

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/shandong-buchang-pharmaceuticals-co

- Industry: Pharmaceuticals
- Headquarters: Xian, China
- Website: www.buchang.com
- Total disclosed funding: $10M
- Latest round: Series F (Aug 1, 2011)
- Investors on record: 1

## About

Founded in 2001 and based in Xian, China, Shandong Buchang Pharmaceuticals Co., Ltd. operates as a pharmaceutical company that focuses on the production and sales of traditional Chinese medicines. Buchang Zhao, the company's founder, graduated from Xi'an Medical University and is also a senior consultant to the Chinese Medical Association of the United States. In August 2011, Shandong Buchang Pharmaceutical raised a series F funding for CNY 66 million from new investor Brightstone Venture Capital. In November 2016, the company was listed on the Shanghai Stock Exchange.

The company is mainly engaged in the research, development, production, and sales of Chinese patent medicines. Its products include Naoxintong Capsules, Wenxin Granules and Danhong Injection, covering a variety of dosage forms such as capsules, granules, and injections. The products are suitable for the treatment of common cardiovascular and cerebrovascular diseases such as stroke, arrhythmia, insufficient blood supply, and ischemic infarction.

The company generates revenue by selling traditional Chinese medicines.

## Funding rounds

- Series F, Aug 1, 2011, $10M — Brightstone Venture Capital

## Investors

- Brightstone Venture Capital (https://capitalatlas.ai/funds/brightstone-venture-capital) — Series F